PITTSBURGH, March 30 (HSMN NewsFeed) — Mylan Inc. (Nasdaq: MYL ) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.2% controlling interest, has received the first tentative approval from the U.S. Food an…
Biopharmaceuticals, Generics, FDA
Mylan, Matrix Laboratories Limited, PEPFAR, Gilead Sciences, Truvada

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Mylan’s Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)”
Leave a Comment